Phraction Scientifics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-06-2024
- Paid Up Capital ₹ 1.00 M
as on 21-06-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.75 Cr
as on 21-06-2024
- Revenue -54.12%
(FY 2021)
- Profit -14.84%
(FY 2021)
- Ebitda -18.19%
(FY 2021)
- Net Worth -126.18%
(FY 2021)
- Total Assets -12.08%
(FY 2021)
About Phraction Scientifics
The Company is engaged in the Infrastructure And Utilities Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.75 Cr.
Ajay Sreedhar, Arun Sreedhar, Sreedharan Pillai, and Two other members serve as directors at the Company.
- CIN/LLPIN
U33112KL2018PTC054569
- Company No.
054569
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Pathanamthitta, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Phraction Scientifics?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Asok Sreedhar  | Director | 07-Sep-2018 | Current |
| Ajay Sreedhar | Director | 07-Sep-2018 | Current |
| Arun Sreedhar | Director | 09-Mar-2019 | Current |
| Sreedharan Pillai | Director | 07-Sep-2018 | Current |
| Sumadevi Pillai | Director | 07-Sep-2018 | Current |
Financial Performance of Phraction Scientifics.
Phraction Scientifics Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 54.12% decrease. The company also saw a substantial fall in profitability, with a 14.84% decrease in profit. The company's net worth observed a substantial decline by a decrease of 126.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phraction Scientifics?
In 2021, Phraction Scientifics had a promoter holding of 81.00% and a public holding of 19.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mallelil Industries Private LimitedActive 17 years 7 monthsAjay Sreedhar, Sreedharan Pillai and 2 more are mutual person
- Georgees Square Private LimitedActive 2 years 6 months
Sreedharan Pillai and Asok Sreedhar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Sep 2022 | ₹1.75 Cr | Open |
How Many Employees Work at Phraction Scientifics?
Unlock and access historical data on people associated with Phraction Scientifics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phraction Scientifics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phraction Scientifics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
